There is More to Life than Revascularization: Therapeutic Targeting of Myocardial Ischemia/Reperfusion Injury
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5922.2010.00190.x/fullpdf
Reference125 articles.
1. Mortality by cause for eight regions of the world: Global burden of disease study;Murray;Lancet,1997
2. Time to treatment influences the impact of ST-segment resolution on one-year prognosis: Insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial;Fu;Circulation,2001
3. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: Is the slope of the curve the shape of the future?;Gersh;JAMA,2005
4. The cell biology of acute myocardial ischemia;Jennings;Annu Rev Med,1991
5. In vivo myocardial cell pH in the dog. Response to ischemia and infusion of alkali;Effros;J Clin Invest,1975
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Traditional Chinese medication qili qiangxin capsule protects against myocardial ischemia-reperfusion injury through suppressing autophagy via the phosphoinositide 3-kinase/protein kinase B/forkhead box O3 axis;Journal of Ethnopharmacology;2025-01
2. Management of ROS and Regulatory Cell Death in Myocardial Ischemia–Reperfusion Injury;Molecular Biotechnology;2024-06-09
3. Compound Danshen Tablets ameliorate myocardial ischemia/reperfusion injury-induced ventricular remodeling by regulating autophagy via AMPK/mTOR signaling pathway;Chinese Herbal Medicines;2024-04
4. Protective effect of Xinmai'an tablets via mediation of the AMPK/SIRT1/PGC-1α signaling pathway on myocardial ischemia-reperfusion injury in rats;Phytomedicine;2023-11
5. Pharmacological Cardioprotection against Ischemia Reperfusion Injury—The Search for a Clinical Effective Therapy;Cells;2023-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3